• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者感知:GBA 相关 PD 的前驱期更短且更严重。

Patient's perception: shorter and more severe prodromal phase in GBA-associated PD.

机构信息

Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.

German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.

出版信息

Eur J Neurol. 2019 Apr;26(4):694-698. doi: 10.1111/ene.13776. Epub 2018 Sep 14.

DOI:10.1111/ene.13776
PMID:30107068
Abstract

BACKGROUND

Prevalence and time of occurrence of prodromal symptoms of Parkinson's disease (PD) in relation to the onset of classical motor manifestation varies between patients. Possible modifying factors might be different genetic architectures predisposing to varying burden of manifestations.

OBJECTIVES

To characterize the prodromal phase in PD patients with heterozygous mutations in the GBA gene compared to PD patients without GBA mutation.

METHODS

In a retrospective design, 151 participants [47 PD patients carrying a GBA mutation (PD ), 52 idiopathic PD patients (PD ), 52 healthy elderly (CON)] underwent a validated structured interview designed to assess prevalence and time of occurrence of prodromal symptoms.

RESULTS

PD showed a higher prevalence of prodromal symptoms and almost simultaneous occurrence of non-motor and early motor symptoms shortly before PD diagnosis whereas PD reported a longer prodromal phase starting with non-motor symptoms.

CONCLUSION

The short and severe prodromal phase in PD might call for shorter assessment intervals in yet premanifest GBA mutation carriers.

摘要

背景

帕金森病(PD)前驱症状的出现频率和时间与经典运动表现的出现时间在不同患者之间存在差异。可能的修饰因素可能是导致表现负担不同的不同遗传结构。

目的

与无 GBA 突变的 PD 患者相比,描述 GBA 基因突变的 PD 患者的前驱期特征。

方法

在回顾性设计中,151 名参与者[47 名携带 GBA 突变的 PD 患者(PD )、52 名特发性 PD 患者(PD )、52 名健康老年人(CON)]接受了一项经过验证的结构化访谈,旨在评估前驱症状的发生率和出现时间。

结果

PD 前驱症状的发生率较高,且非运动和早期运动症状几乎同时发生,在 PD 诊断前不久;而 PD 报告的前驱期较长,从非运动症状开始。

结论

PD 前驱期短且严重,可能需要在 GBA 突变携带者尚未出现症状前进行更短的评估间隔。

相似文献

1
Patient's perception: shorter and more severe prodromal phase in GBA-associated PD.患者感知:GBA 相关 PD 的前驱期更短且更严重。
Eur J Neurol. 2019 Apr;26(4):694-698. doi: 10.1111/ene.13776. Epub 2018 Sep 14.
2
Prevalence of pre-diagnostic symptoms did not differ between LRRK2-related, GBA-related and idiopathic patients with Parkinson's disease.LRRK2 相关、GBA 相关和特发性帕金森病患者的预诊断症状的患病率没有差异。
Parkinsonism Relat Disord. 2018 Dec;57:72-76. doi: 10.1016/j.parkreldis.2018.08.007. Epub 2018 Aug 14.
3
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.GBA 突变阳性队列中帕金森病前驱临床标志物的演变
JAMA Neurol. 2015 Feb;72(2):201-8. doi: 10.1001/jamaneurol.2014.2950.
4
Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA-related Parkinson's disease.前驱性黑质超声检查否定了 GBA 相关帕金森病的底物蓄积与发病风险之间的关联。
Eur J Neurol. 2019 Jul;26(7):1013-1018. doi: 10.1111/ene.13927. Epub 2019 Mar 1.
5
Features of -associated Parkinson's disease at presentation in the UK study.英国研究中 - 关联帕金森病的发病特征。
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.
6
Evolution of prodromal parkinsonian features in a cohort of mutation-positive individuals: a 6-year longitudinal study.队列研究中突变阳性个体前驱帕金森特征的演变:一项 6 年纵向研究。
J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1091-1097. doi: 10.1136/jnnp-2019-320394. Epub 2019 Jun 20.
7
Left corticospinal tract could be a biomarker to identify the dual prodromal LRRK2/GBA mutated Parkinson's disease.左侧皮质脊髓束可能是识别双重前驱 LRRK2/GBA 突变帕金森病的生物标志物。
CNS Neurosci Ther. 2024 Jun;30(6):e14728. doi: 10.1111/cns.14728.
8
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles.GBA 相关 PD 患者的认知障碍:与脑脊液 Abeta 和 Tau 谱无直接关联。
Mov Disord. 2017 Dec;32(12):1780-1783. doi: 10.1002/mds.27199. Epub 2017 Nov 2.
9
[The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].[GBA基因发生突变和多态性变异的帕金森病患者的临床特征]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):81-86. doi: 10.17116/jnevro201711710181-86.
10
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.GBA突变型帕金森病中的葡萄糖脑苷脂酶活性
J Clin Neurosci. 2016 Jun;28:185-6. doi: 10.1016/j.jocn.2015.12.004. Epub 2016 Feb 5.

引用本文的文献

1
Prodromal Parkinsonian Features in Carriers of Gaucher Disease Compared to Controls.与对照组相比,戈谢病携带者的帕金森病前驱特征
Life (Basel). 2025 Jun 13;15(6):952. doi: 10.3390/life15060952.
2
Reported Symptoms in Prodromal and Early Motor Parkinson's Disease: A Scoping Review on the Patient Perspective.前驱期和早期运动型帕金森病的报告症状:基于患者视角的范围综述
Mov Disord Clin Pract. 2025 Jun;12(6):721-733. doi: 10.1002/mdc3.70007. Epub 2025 Mar 3.
3
Gaucher disease provides a unique window into Parkinson disease pathogenesis.
戈谢病为帕金森病发病机制的研究提供了一个独特的窗口。
Nat Rev Neurol. 2024 Sep;20(9):526-540. doi: 10.1038/s41582-024-00999-z. Epub 2024 Aug 6.
4
-Associated Parkinson's Disease Is a Distinct Entity.与帕金森病相关联的疾病是一个独特的实体。
Int J Mol Sci. 2024 Jun 28;25(13):7102. doi: 10.3390/ijms25137102.
5
Association of elevated cerebrospinal fluid levels of the longevity protein α-Klotho with a delayed onset of cognitive impairment in Parkinson's disease patients.α-klotho 蛋白脑脊液水平升高与帕金森病患者认知障碍发病延迟有关。
Eur J Neurol. 2024 Oct;31(10):e16388. doi: 10.1111/ene.16388. Epub 2024 Jul 1.
6
Clinical relevance and translational impact of reduced penetrance in genetic movement disorders.遗传运动障碍中基因外显率降低的临床相关性及转化影响
Med Genet. 2022 Aug 12;34(2):151-156. doi: 10.1515/medgen-2022-2128. eCollection 2022 Jun.
7
Progression subtypes in Parkinson's disease identified by a data-driven multi cohort analysis.通过数据驱动的多队列分析确定的帕金森病进展亚型。
NPJ Parkinsons Dis. 2024 May 2;10(1):95. doi: 10.1038/s41531-024-00712-3.
8
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers.纵向认知衰退是非帕金森病表现的GBA1突变携带者的特征。
NPJ Parkinsons Dis. 2024 Apr 22;10(1):88. doi: 10.1038/s41531-024-00706-1.
9
A Comprehensive Assessment of Qualitative and Quantitative Prodromal Parkinsonian Features in Carriers of Gaucher Disease-Identifying Those at the Greatest Risk.全面评估戈谢病携带者的定性和定量前驱帕金森特征——识别那些风险最高的患者。
Int J Mol Sci. 2022 Oct 13;23(20):12211. doi: 10.3390/ijms232012211.
10
GBA-associated PD: chances and obstacles for targeted treatment strategies.GBA 相关 PD:靶向治疗策略的机会与障碍。
J Neural Transm (Vienna). 2022 Sep;129(9):1219-1233. doi: 10.1007/s00702-022-02511-7. Epub 2022 May 31.